Literature DB >> 31032876

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis.

Luis R Goncalves-Ramírez1, Hipólito Gutiérrez2,3, Paol Rojas2, Carlos Cortés2, Ana Serrador2,3, Benigno Ramos2, Jairo Toro2, Ignacio J Amat-Santos2,3, José A San Román2,3.   

Abstract

Mesh：

Year:  2019        PMID： 31032876      PMCID： PMC8086657          DOI： 10.5603/CJ.2019.0047

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  10 in total

1.  Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Authors:  Joanna J Wykrzykowska; Robin P Kraak; Sjoerd H Hofma; Rene J van der Schaaf; E Karin Arkenbout; Alexander J IJsselmuiden; Joëlle Elias; Ivo M van Dongen; Ruben Y G Tijssen; Karel T Koch; Jan Baan; M Marije Vis; Robbert J de Winter; Jan J Piek; Jan G P Tijssen; Jose P S Henriques
Journal:  N Engl J Med       Date:  2017-03-29       Impact factor: 91.245

2.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

3.  Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study.

Authors:  Pannipa Suwannasom; Yohei Sotomi; Taku Asano; Jaryl Ng Chen Koon; Hiroki Tateishi; Yaping Zeng; Erhan Tenekecioglu; Joanna J Wykrzykowska; Nicolas Foin; Robbert J de Winter; John A Ormiston; Patrick W Serruys; Yoshinobu Onuma
Journal:  EuroIntervention       Date:  2017-04-07       Impact factor: 6.534

Review 4.  Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.

Authors:  Robert A Byrne; Giulio G Stefanini; Davide Capodanno; Yoshinobu Onuma; Andreas Baumbach; Javier Escaned; Michael Haude; Stefan James; Michael Joner; Peter Jüni; Adnan Kastrati; Semih Oktay; William Wijns; Patrick W Serruys; Stephan Windecker
Journal:  EuroIntervention       Date:  2018-01-20       Impact factor: 6.534

5.  A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.

Authors:  Patrick W Serruys; Bernard Chevalier; Dariusz Dudek; Angel Cequier; Didier Carrié; Andres Iniguez; Marcello Dominici; René J van der Schaaf; Michael Haude; Luc Wasungu; Susan Veldhof; Lei Peng; Peter Staehr; Maik J Grundeken; Yuki Ishibashi; Hector M Garcia-Garcia; Yoshinobu Onuma
Journal:  Lancet       Date:  2014-09-14       Impact factor: 79.321

6.  Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.

Authors:  Yoshinobu Onuma; Dariusz Dudek; Leif Thuesen; Mark Webster; Koen Nieman; Hector M Garcia-Garcia; John A Ormiston; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2013-10       Impact factor: 11.195

7.  OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.

Authors:  Antonios Karanasos; Cihan Simsek; Muthukarrupan Gnanadesigan; Nienke S van Ditzhuijzen; Raphael Freire; Jouke Dijkstra; Shengxian Tu; Nicolas Van Mieghem; Gijs van Soest; Peter de Jaegere; Patrick W Serruys; Felix Zijlstra; Robert-Jan van Geuns; Evelyn Regar
Journal:  J Am Coll Cardiol       Date:  2014-12-01       Impact factor: 24.094

8.  Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

Authors:  Salvatore Brugaletta; Tommaso Gori; Adrian F Low; Petr Tousek; Eduardo Pinar; Josep Gomez-Lara; Giancarla Scalone; Eberhard Schulz; Mark Y Chan; Viktor Kocka; Jose Hurtado; Juan Antoni Gomez-Hospital; Thomas Münzel; Chi-Hang Lee; Angel Cequier; Mariano Valdés; Petr Widimsky; Patrick W Serruys; Manel Sabaté
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

9.  Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.

Authors:  Juan Luis Gutiérrez-Chico; Carlos Cortés; Michele Schincariol; Ula Limon; Meric Yalcinli; María-Alexandra Durán-Cortés; Milosz Jaguszewski
Journal:  Cardiol J       Date:  2018-05-18       Impact factor: 2.737

10.  1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis.

Authors:  Gregg W Stone; Runlin Gao; Takeshi Kimura; Dean J Kereiakes; Stephen G Ellis; Yoshinobu Onuma; Wai-Fung Cheong; Jennifer Jones-McMeans; Xiaolu Su; Zhen Zhang; Patrick W Serruys
Journal:  Lancet       Date:  2016-01-27       Impact factor: 79.321
  10 in total
  1 in total

1.  Coronary Vasoreactivity after Complete Bioresorption of Absorb BVS at 5-Year Follow-Up.

Authors:  Luis Renier Goncalves-Ramírez; Hipólito Gutíerrez; Fabián Julca; Maximiliano Germán Amado Escañuela; Gretel Varvaro; Ignacio Amat-Santos
Journal:  Arq Bras Cardiol       Date:  2021-02       Impact factor: 2.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.